查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403461

2030 年微生物组定序服务市场预测：按类型、服务、技术、应用、最终用户和地区进行的全球分析

Microbiome Sequencing Services Market Forecasts to 2030 - Global Analysis By Type, Service, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球微生物组定序服务市场规模将达到 15.4 亿美元，预计到 2030 年将达到 36.1 亿美元，预测期内复合年增长率为 12.9%。

微生物组定序服务分析样本中微生物的 DNA，揭示生活在特定环境（例如人类肠道）中的不同微生物群落的详细资讯。这对于推进个人化医疗、疾病诊断以及理解微生物组与各种生态系统之间复杂的相互作用至关重要。这些服务可识别和量化微生物种类，并帮助研究人员和临床医生了解微生物组的组成和功能。

澳洲癌症协会2022年资料更新估计，2022年澳洲将新诊断出162,163例癌症病例，其中男性88,982例，女性73,181例。

扩大生物製药研究

生物製药公司越来越认识到微生物组在人类健康和疾病中发挥的关键作用，为标靶治疗和精准医疗方法的发展铺平了道路。生物製药公司正在利用微生物组定序进行临床前和临床试验，以了解治疗治疗性介入对微生物生态系统的影响。此外，对肠道微生物组的探索尤其因其调节药物代谢、功效和安全性的潜力而受到关注，从而推动了该市场的规模。

高成本

小型研究机构、学术实验室和新兴企业面临独特的财务挑战，由于成本高昂，他们无法彻底实施微生物组定序服务。这些高成本加剧了研究人员和组织的经济障碍，包括样本采集、DNA 提取、文库製备和资料分析。此外，微生物组分析的复杂性需要先进的定序技术和生物资讯学知识，增加了这些服务的整体高成本，阻碍了该市场的规模。

定序技术创新

技术的进步使研究人员能够产生大量资料，有助于更全面地了解不同生态系统中的微生物群落。次世代定序仪（NGS）平台、Illumina和Thermo Fisher等技术大大增加了微生物组定序的深度和广度。此外，提高的定序准确性、更长的读长和增加的通量有助于识别和表征更广泛的微生物物种，从而推动该市场的扩张。

与标准化相关的风险

不同平台和服务供应商之间的协议、方法和资料分析程序缺乏统一性，为比较和解释结果带来了挑战。这种变异性可能导致微生物群落分析的不一致。此外，缺乏样本采集、DNA 萃取和定序文库製备的标准化方法可能会对微生物组资料造成偏差和错误。这不仅影响学术研究，也影响微生物组定序向临床应用和法律规范的过渡，阻碍市场成长。

COVID-19 的影响

COVID-19 的爆发以多种方式对微生物组定序服务市场产生了负面影响。供应链中断、物流挑战和实验室活动限制阻碍了微生物组定序服务的无缝运作。许多研究机构和生技公司面临财务困难，进一步限制了微生物组研究和定序服务的投资。此外，临床试验和学术研究活动减少了学术和工业环境中对微生物组定序服务的需求，阻碍了该市场的成长。

全基因组定序部分预计在预测期内规模最大

全基因组定序领域预计将在估计和预测期间占据最大份额，因为它能够获得广泛的遗传资讯，从而能够检测微生物群落内的稀有物种和变异。此外，该技术还能对生物体的整个 DNA 进行定序，从而可以详细了解其基因组成、功能元件和潜在的毒力因子。该技术有助于加速发现并指导治疗性介入，从而推动该领域的成长。

连接定序（SBL）领域预计在预测期内复合年增长率最高

连接定序（SBL）领域预计在预测期内复合年增长率最高。在 SBL 中，DNA 片段使用特定的接头连接形成串联结构。这提供了诸如高精度、长读长以及从困难的基因组区域检索资讯的能力等优点。此外，研究人员和服务供应商可以全面了解微生物基因组，帮助了解群落动态、功能潜力和宿主-微生物组相互作用。

比最大的地区

人们越来越认识到微生物组对健康和疾病的影响，再加上精准医疗和个体化医疗保健的重要性日益增加，在估计期间占据了最大的市场占有率。中国、日本、韩国和印度等国家正在促进研究机构、生技公司和定序服务供应商之间的合作。此外，随着研究能力和基础设施的不断加强，高通量定序技术和生物资讯能力的进步进一步推动了该地区的成长。

复合年增长率最高的地区：

预计欧洲在预测期内的复合年增长率最高。欧洲各地的多样化人口为微生物组研究提供了丰富的环境，使研究人员能够研究微生物组成的变化及其对区域健康模式的影响。此外，Illumina, Inc.、Macrogen, Inc.、Genewiz 和 Eurofins Scientific 等主要企业为个人化医疗、农业实践和对微生物生态系统的了解做出了重大贡献，正在推动该地区的扩张。我是。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球微生物组定序服务市场：按类型

  • 霰弹枪序列
  • 全基因组序列测定
  • 放大器序列测定
  • 其他类型

第六章全球微生物组定序服务市场：依服务分类

  • 资料分析
  • 样品製备
  • 序列库的製备
  • 其他服务

第七章全球微生物组定序服务市场：依技术分类

  • 标靶基因序列测定
  • 连接定序 (SBL)
  • 合成定序(SBS)
  • 其他技术

第八章全球微生物组定序服务市场：依应用分类

  • 中枢神经系统疾病
  • 肿瘤学
  • 消化系统疾病
  • 感染疾病
  • 其他用途

第九章全球微生物组定序服务市场：依最终用户分类

  • 学术研究所
  • 製药和生物技术公司
  • 其他最终用户

第十章全球微生物组定序服务市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • DNA Genotek Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Metabiomics
  • CosmosID
  • Zymo Research Corporation
  • PerkinElmer, Inc.
  • BGI Genomics Co., Ltd.
  • Rancho Biosciences
  • Baseclear BV
  • Diversigen, Inc.
  • Merieux Nutrisciences Corporations
  • Clinical Microbiomics AS
  • Bio-Rad Laboratories, Inc.
  • Genewiz Inc.
Product Code: SMRC24686

According to Stratistics MRC, the Global Microbiome Sequencing Services Market is accounted for $1.54 billion in 2023 and is expected to reach $3.61 billion by 2030 growing at a CAGR of 12.9% during the forecast period. Microbiome sequencing services analyze the DNA of microorganisms in a sample to reveal details about the diverse community of microbes living in a particular environment, like the human gut. It is crucial for personalized medicine, disease diagnostics, and advancing our understanding of the intricate interplay between microbiota and various ecosystems. These services identify and quantify microbial species, helping researchers and clinicians understand the microbiome's composition and function.

According to the data updated by Cancer Australia in 2022, it was estimated that 162,163 new cases of cancer would be diagnosed in Australia in 2022, out of which 88,982 would be males and 73,181 females.

Market Dynamics:

Driver:

Expanding biopharmaceutical research

Biopharmaceutical companies are increasingly recognizing the pivotal role of the microbiome in influencing human health and disease, paving the way for the development of targeted therapies and precision medicine approaches. Biopharmaceutical companies leverage microbiome sequencing to conduct preclinical and clinical trials, aiming to understand the impact of therapeutic interventions on microbial ecosystems. Furthermore, the exploration of the gut microbiome, in particular, has garnered attention for its potential in modulating drug metabolism, efficacy, and safety, which is boosting this market size.

Restraint:

High cost

Smaller research institutions, academic laboratories, and startups face unique financial challenges that prevent their capacity to conduct thorough microbiome sequencing services due to high costs. Financial obstacles for researchers and organizations are made worse by these high costs, which include sample collection, DNA extraction, library preparation, and data analysis. Additionally, the complexity of microbiome analysis, which necessitates sophisticated sequencing technologies and bioinformatics knowledge, adds to the overall high cost of these services, which is hindering this market size.

Opportunity:

Innovations in sequencing technologies

The technological strides enable researchers to generate vast amounts of data, facilitating a more comprehensive understanding of microbial communities within diverse ecosystems. Technologies such as next-generation sequencing (NGS) platforms, Illumina's, and Thermo Fisher's offerings have significantly enhanced the depth and breadth of microbiome sequencing. Furthermore, improved sequencing accuracy, longer read lengths, and increased throughput contribute to the identification and characterization of a wider range of microbial species, thereby propelling this market expansion.

Threat:

Risks associated with standardization

The lack of uniformity in protocols, methodologies, and data analysis procedures across different platforms and service providers introduces challenges in comparing and interpreting results. This variability can lead to inconsistencies in microbial community profiling. Furthermore, the absence of standardized practices in sample collection, DNA extraction, and sequencing library preparation can contribute to biases and errors in microbiome data. This not only affects academic research but also impacts the translation of microbiome sequencing into clinical applications and regulatory frameworks, hindering the market's growth.

COVID-19 Impact

The COVID-19 pandemic has negatively impacted the microbiome sequencing services market in various ways. Disruptions in supply chains, logistical challenges, and restrictions on laboratory activities have impeded the seamless operation of microbiome sequencing services. Many research institutions and biotechnology companies faced financial constraints, further limiting investments in microbiome studies and sequencing services. Additionally, clinical trials and academic research activities decreased demand for microbiome sequencing services in both academic and industrial settings, impeding this market's growth.

The whole-genome sequencing segment is expected to be the largest during the forecast period

The whole-genome sequencing segment is estimated to hold the largest share during the forecast period, due to its ability to capture a broad spectrum of genetic information, enabling the detection of rare species and variations within microbial communities. Additionally, this technique involves sequencing the entire DNA of an organism, providing a detailed understanding of its genetic makeup, functional elements, and potential virulence factors. It is instrumental in fueling discoveries and guiding therapeutic interventions, thereby driving this segment's growth.

The sequencing by ligation (SBL) segment is expected to have the highest CAGR during the forecast period

The sequencing by ligation (SBL) segment is anticipated to have highest CAGR during the forecast period. In SBL, DNA fragments are ligated together using specific adapters, forming a concatemeric structure. This offers advantages such as high accuracy, long read lengths, and the ability to capture information from challenging genomic regions. In addition, researchers and service providers obtain comprehensive insights into microbial genomes, aiding in the understanding of community dynamics, functional potential, and host-microbiome interactions, which are boosting this market expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing awareness of the microbiome's impact on health and disease, coupled with a rising emphasis on precision medicine and personalized healthcare. Countries like China, Japan, South Korea, and India foster collaborations between research institutions, biotechnology companies, and sequencing service providers. In addition, as research capabilities and infrastructure continue to strengthen the advancements in high-throughput sequencing technologies and bioinformatics capabilities further propel the region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. The diverse population across Europe provides a rich landscape for microbiome studies, enabling researchers to explore variations in microbial compositions and their impact on regional health patterns. Key players such as Illumina, Inc., Macrogen, Inc., Genewiz, and Eurofins Scientific also contribute significantly to advancements in personalized medicine, agricultural practices, and our understanding of microbial ecosystems, thus driving this region's expansion.

Key players in the market:

Some of the key players in the Microbiome Sequencing Services Market include DNA Genotek Inc., Thermo Fisher Scientific Inc., Illumina, Inc., Metabiomics, CosmosID, Zymo Research, Corporation, PerkinElmer, Inc., BGI Genomics Co., Ltd., Rancho Biosciences, Baseclear BV, Diversigen, Inc., Merieux Nutrisciences Corporations, Clinical Microbiomics AS, Bio-Rad Laboratories, Inc. and Genewiz Inc.

Key Developments:

In November 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies announced the launch of the Global Health Access Initiative to support access to pathogen sequencing tools for public health in low- and middle-income countries (LMICs).

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In July 2023, Bio-Rad Laboratories, Inc. announced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

Types Covered:

  • Shotgun Sequencing
  • Whole-genome Sequencing
  • Amplicon Sequencing
  • Other Types

Services Covered:

  • Data Analysis
  • Sample Preparation
  • Sequencing Library Preparation
  • Other Services

Technologies Covered:

  • Targeted Gene Sequencing
  • Sequencing by Ligation (SBL)
  • Sequencing by Synthesis (SBS)
  • Other Technologies

Applications Covered:

  • CNS Diseases
  • Oncology
  • Gastrointestinal Diseases
  • Infectious Diseases
  • Other Applications

End Users Covered:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microbiome Sequencing Services Market, By Type

  • 5.1 Introduction
  • 5.2 Shotgun Sequencing
  • 5.3 Whole-genome Sequencing
  • 5.4 Amplicon Sequencing
  • 5.5 Other Types

6 Global Microbiome Sequencing Services Market, By Service

  • 6.1 Introduction
  • 6.2 Data Analysis
  • 6.3 Sample Preparation
  • 6.4 Sequencing Library Preparation
  • 6.5 Other Services

7 Global Microbiome Sequencing Services Market, By Technology

  • 7.1 Introduction
  • 7.2 Targeted Gene Sequencing
  • 7.3 Sequencing by Ligation (SBL)
  • 7.4 Sequencing by Synthesis (SBS)
  • 7.5 Other Technologies

8 Global Microbiome Sequencing Services Market, By Application

  • 8.1 Introduction
  • 8.2 CNS Diseases
  • 8.3 Oncology
  • 8.4 Gastrointestinal Diseases
  • 8.5 Infectious Diseases
  • 8.6 Other Applications

9 Global Microbiome Sequencing Services Market, By End User

  • 9.1 Introduction
  • 9.2 Academic and Research Institutes
  • 9.3 Pharmaceutical and Biotechnology Companies
  • 9.4 Other End Users

10 Global Microbiome Sequencing Services Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 DNA Genotek Inc.
  • 12.2 Thermo Fisher Scientific Inc.
  • 12.3 Illumina, Inc.
  • 12.4 Metabiomics
  • 12.5 CosmosID
  • 12.6 Zymo Research Corporation
  • 12.7 PerkinElmer, Inc.
  • 12.8 BGI Genomics Co., Ltd.
  • 12.9 Rancho Biosciences
  • 12.10 Baseclear BV
  • 12.11 Diversigen, Inc.
  • 12.12 Merieux Nutrisciences Corporations
  • 12.13 Clinical Microbiomics AS
  • 12.14 Bio-Rad Laboratories, Inc.
  • 12.15 Genewiz Inc.

List of Tables

  • Table 1 Global Microbiome Sequencing Services Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 4 Global Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 5 Global Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 6 Global Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 7 Global Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 8 Global Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 9 Global Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 10 Global Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 11 Global Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 12 Global Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 14 Global Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 15 Global Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 16 Global Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 17 Global Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 18 Global Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 19 Global Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 20 Global Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 21 Global Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 22 Global Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 23 Global Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 24 Global Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 25 Global Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 26 Global Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 27 North America Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 28 North America Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 29 North America Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 30 North America Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 31 North America Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 32 North America Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 33 North America Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 34 North America Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 35 North America Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 36 North America Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 37 North America Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 38 North America Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 39 North America Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 40 North America Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 41 North America Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 42 North America Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 43 North America Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 44 North America Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 45 North America Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 46 North America Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 47 North America Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 48 North America Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 49 North America Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 50 North America Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 51 North America Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 52 North America Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 53 Europe Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 54 Europe Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 55 Europe Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 56 Europe Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 57 Europe Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 58 Europe Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 59 Europe Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 60 Europe Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 61 Europe Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 62 Europe Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 63 Europe Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 64 Europe Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 65 Europe Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 66 Europe Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 67 Europe Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 68 Europe Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 69 Europe Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 70 Europe Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 71 Europe Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 72 Europe Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 73 Europe Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 74 Europe Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 75 Europe Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 76 Europe Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 77 Europe Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 78 Europe Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 79 Asia Pacific Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 80 Asia Pacific Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 81 Asia Pacific Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 82 Asia Pacific Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 83 Asia Pacific Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 84 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 85 Asia Pacific Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 86 Asia Pacific Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 87 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 88 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 89 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 90 Asia Pacific Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 91 Asia Pacific Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 92 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 93 Asia Pacific Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 94 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 95 Asia Pacific Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 96 Asia Pacific Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 97 Asia Pacific Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 98 Asia Pacific Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 99 Asia Pacific Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 100 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 101 Asia Pacific Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 102 Asia Pacific Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 103 Asia Pacific Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 104 Asia Pacific Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 105 South America Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 106 South America Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 107 South America Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 108 South America Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 109 South America Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 110 South America Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 111 South America Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 112 South America Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 113 South America Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 114 South America Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 115 South America Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 116 South America Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 117 South America Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 118 South America Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 119 South America Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 120 South America Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 121 South America Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 122 South America Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 123 South America Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 124 South America Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 125 South America Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 126 South America Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 127 South America Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 128 South America Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 129 South America Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 130 South America Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 131 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Country (2021-2030) ($MN)
  • Table 132 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 133 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 134 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Whole-genome Sequencing (2021-2030) ($MN)
  • Table 135 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Amplicon Sequencing (2021-2030) ($MN)
  • Table 136 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 137 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Service (2021-2030) ($MN)
  • Table 138 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Data Analysis (2021-2030) ($MN)
  • Table 139 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 140 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing Library Preparation (2021-2030) ($MN)
  • Table 141 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Services (2021-2030) ($MN)
  • Table 142 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Technology (2021-2030) ($MN)
  • Table 143 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Targeted Gene Sequencing (2021-2030) ($MN)
  • Table 144 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing by Ligation (SBL) (2021-2030) ($MN)
  • Table 145 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Sequencing by Synthesis (SBS) (2021-2030) ($MN)
  • Table 146 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 147 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Application (2021-2030) ($MN)
  • Table 148 Middle East & Africa Microbiome Sequencing Services Market Outlook, By CNS Diseases (2021-2030) ($MN)
  • Table 149 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 150 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Gastrointestinal Diseases (2021-2030) ($MN)
  • Table 151 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 152 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 153 Middle East & Africa Microbiome Sequencing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 154 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 155 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 156 Middle East & Africa Microbiome Sequencing Services Market Outlook, By Other End Users (2021-2030) ($MN)